Next-generation DNA synthesis using enzymes
Company is active
Event Year: 2022
Company is active
Event Year: 2022
Ansa Biotechnologies is pioneering a novel approach to DNA synthesis, leveraging enzymatic processes to achieve unprecedented speed, accuracy, and purity compared to traditional methods. For the past 35 years, DNA manufacturing has largely relied on chemical synthesis techniques. Ansa's innovative enzyme-based technology holds the potential to revolutionize biological research and biotechnology, significantly accelerating advancements in therapeutics, diagnostics, and biomanufacturing. This next-generation approach promises to overcome the limitations of existing methods, enabling researchers and companies to unlock new possibilities in diverse fields.
Ansa Biotechnologies is pioneering a novel approach to DNA synthesis, leveraging enzymatic processes to achieve unprecedented speed, accuracy, and purity compared to traditional methods. For the past 35 years, DNA manufacturing has largely relied on chemical synthesis techniques. Ansa's innovative enzyme-based technology holds the potential to revolutionize biological research and biotechnology, significantly accelerating advancements in therapeutics, diagnostics, and biomanufacturing. This next-generation approach promises to overcome the limitations of existing methods, enabling researchers and companies to unlock new possibilities in diverse fields.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2020
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2020
Healthcare
Healthcare
Healthcare -> Industrial Bio
Healthcare -> Industrial Bio
Team size: 72
Hiring: No
Team size: 72
Hiring: No